BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1537 related articles for article (PubMed ID: 27104887)

  • 1. Aerobic exercise training in the treatment of non-alcoholic fatty liver disease related fibrosis.
    Linden MA; Sheldon RD; Meers GM; Ortinau LC; Morris EM; Booth FW; Kanaley JA; Vieira-Potter VJ; Sowers JR; Ibdah JA; Thyfault JP; Laughlin MH; Rector RS
    J Physiol; 2016 Sep; 594(18):5271-84. PubMed ID: 27104887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treating NAFLD in OLETF rats with vigorous-intensity interval exercise training.
    Linden MA; Fletcher JA; Morris EM; Meers GM; Laughlin MH; Booth FW; Sowers JR; Ibdah JA; Thyfault JP; Rector RS
    Med Sci Sports Exerc; 2015 Mar; 47(3):556-67. PubMed ID: 24983336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endurance training lowers ribosome density despite increasing ribosome biogenesis markers in rodent skeletal muscle.
    Romero MA; Mobley CB; Linden MA; Meers GM; Martin JS; Young KC; Rector RS; Roberts MD
    BMC Res Notes; 2017 Aug; 10(1):399. PubMed ID: 28800772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exercise initiated after the onset of insulin resistance improves trabecular microarchitecture and cortical bone biomechanics of the tibia in hyperphagic Otsuka Long Evans Tokushima Fatty rats.
    Ortinau LC; Linden MA; Dirkes RK; Rector RS; Hinton PS
    Bone; 2017 Oct; 103():188-199. PubMed ID: 28711659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Silymarin suppresses hepatic stellate cell activation in a dietary rat model of non-alcoholic steatohepatitis: analysis of isolated hepatic stellate cells.
    Kim M; Yang SG; Kim JM; Lee JW; Kim YS; Lee JI
    Int J Mol Med; 2012 Sep; 30(3):473-9. PubMed ID: 22710359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dietary modification dampens liver inflammation and fibrosis in obesity-related fatty liver disease.
    Larter CZ; Yeh MM; Haigh WG; Van Rooyen DM; Brooling J; Heydet D; Nolan CJ; Teoh NC; Farrell GC
    Obesity (Silver Spring); 2013 Jun; 21(6):1189-99. PubMed ID: 23666886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Daily exercise vs. caloric restriction for prevention of nonalcoholic fatty liver disease in the OLETF rat model.
    Rector RS; Uptergrove GM; Morris EM; Borengasser SJ; Laughlin MH; Booth FW; Thyfault JP; Ibdah JA
    Am J Physiol Gastrointest Liver Physiol; 2011 May; 300(5):G874-83. PubMed ID: 21350190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combining metformin and aerobic exercise training in the treatment of type 2 diabetes and NAFLD in OLETF rats.
    Linden MA; Fletcher JA; Morris EM; Meers GM; Kearney ML; Crissey JM; Laughlin MH; Booth FW; Sowers JR; Ibdah JA; Thyfault JP; Rector RS
    Am J Physiol Endocrinol Metab; 2014 Feb; 306(3):E300-10. PubMed ID: 24326426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular drivers of non-alcoholic steatohepatitis are sustained in mild-to-late fibrosis progression in a guinea pig model.
    Ipsen DH; Skat-Rørdam J; Tsamouri MM; Latta M; Lykkesfeldt J; Tveden-Nyborg P
    Mol Genet Genomics; 2019 Jun; 294(3):649-661. PubMed ID: 30759275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is Western Diet-Induced Nonalcoholic Steatohepatitis in Ldlr-/- Mice Reversible?
    Lytle KA; Jump DB
    PLoS One; 2016; 11(1):e0146942. PubMed ID: 26761430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tranilast, an antifibrogenic agent, ameliorates a dietary rat model of nonalcoholic steatohepatitis.
    Uno M; Kurita S; Misu H; Ando H; Ota T; Matsuzawa-Nagata N; Kita Y; Nabemoto S; Akahori H; Zen Y; Nakanuma Y; Kaneko S; Takamura T
    Hepatology; 2008 Jul; 48(1):109-18. PubMed ID: 18571789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulating fibroblast growth factor 21 in hyperphagic OLETF rats with daily exercise and caloric restriction.
    Fletcher JA; Meers GM; Laughlin MH; Ibdah JA; Thyfault JP; Rector RS
    Appl Physiol Nutr Metab; 2012 Dec; 37(6):1054-62. PubMed ID: 22891896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vitronectin deficiency attenuates hepatic fibrosis in a non-alcoholic steatohepatitis-induced mouse model.
    Hayashida M; Hashimoto K; Ishikawa T; Miyamoto Y
    Int J Exp Pathol; 2019 Apr; 100(2):72-82. PubMed ID: 30887659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imaging Fibrogenesis in a Diet-Induced Model of Nonalcoholic Steatohepatitis (NASH).
    Hartimath SV; Boominathan R; Soh V; Cheng P; Deng X; Chong YC; Yong FF; Tan PW; Han W; Robins EG; Goggi JL
    Contrast Media Mol Imaging; 2019; 2019():6298128. PubMed ID: 31866798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diet and exercise reduce pre-existing NASH and fibrosis and have additional beneficial effects on the vasculature, adipose tissue and skeletal muscle via organ-crosstalk.
    van den Hoek AM; de Jong JCBC; Worms N; van Nieuwkoop A; Voskuilen M; Menke AL; Lek S; Caspers MPM; Verschuren L; Kleemann R
    Metabolism; 2021 Nov; 124():154873. PubMed ID: 34478753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Docosahexaenoic acid blocks progression of western diet-induced nonalcoholic steatohepatitis in obese Ldlr-/- mice.
    Lytle KA; Wong CP; Jump DB
    PLoS One; 2017; 12(4):e0173376. PubMed ID: 28422962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exercise of high intensity ameliorates hepatic inflammation and the progression of NASH.
    Fredrickson G; Barrow F; Dietsche K; Parthiban P; Khan S; Robert S; Demirchian M; Rhoades H; Wang H; Adeyi O; Revelo XS
    Mol Metab; 2021 Nov; 53():101270. PubMed ID: 34118476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progression of non-alcoholic steatosis to steatohepatitis and fibrosis parallels cumulative accumulation of danger signals that promote inflammation and liver tumors in a high fat-cholesterol-sugar diet model in mice.
    Ganz M; Bukong TN; Csak T; Saha B; Park JK; Ambade A; Kodys K; Szabo G
    J Transl Med; 2015 Jun; 13():193. PubMed ID: 26077675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human amnion epithelial cells and their soluble factors reduce liver fibrosis in murine non-alcoholic steatohepatitis.
    Kuk N; Hodge A; Sun Y; Correia J; Alhomrani M; Samuel C; Moore G; Lim R; Sievert W
    J Gastroenterol Hepatol; 2019 Aug; 34(8):1441-1449. PubMed ID: 30821873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Saturated fat and cholesterol are critical to inducing murine metabolic syndrome with robust nonalcoholic steatohepatitis.
    Mells JE; Fu PP; Kumar P; Smith T; Karpen SJ; Anania FA
    J Nutr Biochem; 2015 Mar; 26(3):285-92. PubMed ID: 25577467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 77.